 |
|
|
| |
Multi-Target DAA Therapy is Associated with Superior Immunologic Recovery in HIV/HCV Co-Infected Patients
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
S. SHRIVASTAVA1, M. BHATTA1,2, H. WARD1,2, R. LEE1, E. ROSENTHAL1, H. MASUR2, S. KOTTILIL1, and E. WILSON1
1 Institute for Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201
2 Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892
|
| |
|
|
|
|
|
